Immunome Inc. (IMNM)
NASDAQ: IMNM
· Real-Time Price · USD
10.26
0.32 (3.22%)
At close: Aug 15, 2025, 3:59 PM
10.40
1.41%
After-hours: Aug 15, 2025, 06:45 PM EDT
Immunome Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -43.4M | -41.64M | -80.25M | -47.1M | -36.12M | -129.49M | -92.63M | -4.34M | -5.56M | -4.27M | -7.79M | -8.53M | -8.92M | -11.65M | -7.85M | -7.72M | -5.24M | -3.9M |
Depreciation & Amortization | 720K | 726K | 595K | 571K | 673K | 263K | 257K | 166K | 157K | 148K | 260K | 114K | 121K | 136K | 118K | 286K | 175K | 176K |
Stock-Based Compensation | 5.35M | 5.7M | 5.47M | 4.89M | 3.23M | 2.16M | 2.88M | 1.08M | 1.03M | 1.22M | 1.35M | 1.34M | 1.33M | 1.31M | 1.22M | 1.16M | 749K | 325K |
Other Working Capital | -6.81M | -13.22M | -3.98M | 4.34M | 2.9M | 2.09M | -7.24M | -4.64M | -1.89M | 26.38M | 227K | 1.62M | -1.98M | 3.06M | 6K | 537K | 2.36M | -1.91M |
Other Non-Cash Items | -314K | -818K | 26.84M | 14.82M | 5.96M | 111.42M | 78.37M | 332K | 758K | 833K | 2.24M | 12K | 175K | -12K | 12K | -5K | -2K | -1K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | 1.59M | n/a | -758K | -833K | -2.24M | n/a | n/a | n/a | n/a | n/a | -500K | n/a |
Change in Working Capital | -11.76M | -17.03M | 5.29M | -7.35M | 2.87M | 4.48M | -7.92M | -5.85M | -1.3M | 27.07M | -512K | -504K | -584K | 3.84M | -302K | 2.14M | 1.08M | -137K |
Operating Cash Flow | -49.4M | -53.05M | -42.06M | -34.17M | -23.4M | -11.17M | -17.46M | -8.61M | -5.67M | 24.17M | -6.68M | -7.57M | -8.06M | -6.38M | -6.8M | -4.14M | -3.74M | -3.54M |
Capital Expenditures | -905K | -3.67M | -1.38M | -1.54M | -2.34M | -2.16M | -349K | -36K | -340K | -106K | -72K | n/a | -170K | -6K | -14K | -26K | -8K | -31K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | -20.06M | 9.28M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -123.27M | n/a | -73.87M | n/a | -112.69M | n/a | -38.93M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 60M | 15M | 85M | 30M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -6.25M | -249K | -4.36M | 33.34M | -15.01M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -64.17M | 5.09M | 9.76M | 24.1M | -81.69M | -37.23M | -30M | -36K | -340K | -106K | -72K | n/a | -170K | -6K | -14K | -26K | -8K | -31K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -16K | -28K | -34K | -35K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | -233.73M | 304K | -10.56M | 64M | 61M | n/a | n/a | -32K | n/a | n/a | 32K | -179K | 388K | 27.34M | 111K |
Financial Cash Flow | -55K | 162.23M | 20.09M | 305K | 694K | 219.44M | 55.5M | 60.88M | n/a | 34K | 32K | n/a | n/a | 32K | -195K | 585K | 27.3M | 76K |
Net Cash Flow | -113.63M | 114.26M | -12.22M | -9.76M | -104.39M | 171.04M | 8.04M | 52.23M | -6.01M | 24.1M | -6.75M | -7.57M | -8.23M | -6.35M | -7.01M | -3.59M | 23.55M | -3.49M |
Free Cash Flow | -50.31M | -56.72M | -43.44M | -35.71M | -25.74M | -13.33M | -17.81M | -8.65M | -6.01M | 24.07M | -6.75M | -7.57M | -8.23M | -6.38M | -6.82M | -4.17M | -3.75M | -3.57M |